Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hum Reprod ; 19(8): 1806-10, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15218001

RESUMEN

We report two cases of acute eosinophilic pneumonia induced by i.m. administration of progesterone used as luteal phase support after IVF. For both patients, the symptoms began 3 weeks after the first injection of progesterone. Both patients were in respiratory distress, and one of them required ventilatory assistance for a week, with 5 days in the intensive care unit. Symptoms improved as the i.m. form was shifted to a vaginal form of progesterone together with the administration of corticosteroids. Sesame oil (used as excipient) and benzyl alcohol (used as preservative) could both be incriminated in the development of the hypersensitivity reaction. The need for luteal phase support is clearly established in IVF cycles with GnRH agonist protocols, and progesterone is the generally recommended compound. However, there is no definitive consensus regarding the optimal route of administration of progesterone. These two cases of acute drug-induced disease show that the use of i.m. progesterone can be associated with a severe morbidity in otherwise healthy young patients. This is an additional argument to advocate the use of vaginal progesterone as luteal support in IVF.


Asunto(s)
Fertilización In Vitro/efectos adversos , Fase Luteínica , Progesterona/efectos adversos , Eosinofilia Pulmonar/inducido químicamente , Enfermedad Aguda , Adulto , Alcohol Bencilo , Excipientes , Femenino , Humanos , Inyecciones Intramusculares , Embarazo , Resultado del Embarazo , Conservadores Farmacéuticos , Progesterona/administración & dosificación , Eosinofilia Pulmonar/diagnóstico por imagen , Radiografía , Aceite de Sésamo
2.
Crit Care Med ; 29(3): 581-8, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11373424

RESUMEN

OBJECTIVE: To examine the effects of adrenergic stimulation on hepatosplanchnic perfusion, oxygen extraction, and tumor necrosis factor-alpha production during endotoxic shock. DESIGN: In vivo, prospective, randomized, controlled, repeated-measures, experimental study. SETTING: Experimental physiology laboratory in a university teaching hospital. SUBJECTS: Twenty-one anesthetized and mechanically ventilated dogs. INTERVENTIONS: An intrapericardial catheter was positioned. Catheters for blood sampling were inserted into the right femoral artery, hepatic vein, portal vein, and pulmonary artery. Ultrasonic flow probes were placed around the portal vein, the hepatic artery, the mesenteric artery, the left renal artery, and the left femoral artery. Animals received 2 mg/kg of Escherichia coli endotoxin, followed by fluid resuscitation. Seven dogs received intravenous isoproterenol (0.1 microg/kg x min(-1)), seven received phenylephrine (1 microg/kg x min(-1)), and seven served as controls. Thirty minutes later, cardiac tamponade was introduced to study organ perfusion and tissue oxygen extraction capabilities. MAIN RESULTS: The isoproterenol group had a higher cardiac index and stroke index and lower systemic vascular resistance than the other groups. The phenylephrine group had a higher arterial pressure but a lower cardiac index than the isoproterenol group. The isoproterenol group had a higher hepatic artery blood flow than the other groups and a higher portal and mesenteric flow than the control group. Liver and gut mucosal blood flow was greater in the isoproterenol than in the phenylephrine group. The isoproterenol group had a lower global critical oxygen delivery than the other groups (8.8 +/- 1.3 vs. 13.1 +/- 2.0 (control) and 11.8 +/- 3.3 mL/kg x min(-1) (phenylephrine); both p < .05) and a higher liver critical oxygen extraction ratio than the control group. Isoproterenol tended to attenuate, but phenylephrine significantly increased, blood tumor necrosis factor levels. CONCLUSIONS: During endotoxic shock, beta-stimulation can improve hepatosplanchnic perfusion and enhance tissue oxygen extraction capabilities, whereas alpha-stimulation does not. In addition, alpha-adrenergic stimulation can increase tumor necrosis factor levels.


Asunto(s)
Agonistas alfa-Adrenérgicos/uso terapéutico , Agonistas Adrenérgicos beta/uso terapéutico , Modelos Animales de Enfermedad , Isoproterenol/uso terapéutico , Consumo de Oxígeno/efectos de los fármacos , Fenilefrina/uso terapéutico , Choque Séptico/tratamiento farmacológico , Circulación Esplácnica/efectos de los fármacos , Agonistas alfa-Adrenérgicos/farmacología , Agonistas Adrenérgicos beta/farmacología , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Perros , Evaluación Preclínica de Medicamentos , Monitoreo de Drogas , Femenino , Mucosa Intestinal/irrigación sanguínea , Isoproterenol/farmacología , Masculino , Fenilefrina/farmacología , Estudios Prospectivos , Distribución Aleatoria , Choque Séptico/metabolismo , Choque Séptico/fisiopatología , Volumen Sistólico/efectos de los fármacos , Factores de Tiempo , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/metabolismo , Resistencia Vascular/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA